{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:34:03Z","timestamp":1789155243524,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,10,2]],"date-time":"2009-10-02T00:00:00Z","timestamp":1254441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s11060-009-0022-2","type":"journal-article","created":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T03:38:39Z","timestamp":1254368319000},"page":"291-294","source":"Crossref","is-referenced-by-count":14,"title":["Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma"],"prefix":"10.1007","volume":"97","author":[{"given":"Emmanouel","family":"Saloustros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Zaganas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Mavridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambros","family":"Vamvakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Plaitakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Georgoulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Mavroudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,2]]},"reference":[{"key":"22_CR1","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","volume":"349","author":"R Darnell","year":"2003","unstructured":"Darnell R, Posner J (2003) Paraneoplastic syndromes involving the nervous system. N Engl J Med 349:1543\u20131554","journal-title":"N Engl J Med"},{"key":"22_CR2","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/brain\/awg133","volume":"126","author":"S Shams\u2019ili","year":"2003","unstructured":"Shams\u2019ili S, Grefkens J et al (2003) Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 126:1409\u20131418","journal-title":"Brain"},{"key":"22_CR3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Rosenfeld MR (2008) Paraneoplastic syndromes of the CNS. Lancet Neurol 7:327\u2013340","journal-title":"Lancet Neurol"},{"key":"22_CR4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF00178121","volume":"2","author":"HS Greenberg","year":"1984","unstructured":"Greenberg HS (1984) Paraneoplastic cerebellar degeneration. A clinical and CT study. J Neurooncol 2:377\u2013382","journal-title":"J Neurooncol"},{"key":"22_CR5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11060-007-9368-5","volume":"84","author":"A Bonakis","year":"2007","unstructured":"Bonakis A, Papageorgiou SG, Mandellos D et al (2007) Acute onset paraneoplastic cerebellar degeneration. J Neurooncol 84:329\u2013330","journal-title":"J Neurooncol"},{"key":"22_CR6","doi-asserted-by":"crossref","unstructured":"Frey A, Di Canzio J, Zurakowski D (1998) A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods 1(22):35\u201341","DOI":"10.1016\/S0022-1759(98)00170-7"},{"key":"22_CR7","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1212\/WNL.50.6.1919","volume":"50","author":"AF Carpentier","year":"1998","unstructured":"Carpentier AF, Voltz R, DesChamps T et al (1998) Absence of HuD gene mutations in paraneoplastic small cell lung cancer tissue. Neurology 50:1919","journal-title":"Neurology"},{"issue":"1","key":"22_CR8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00404-008-0822-1","volume":"280","author":"BH Goldstein","year":"2009","unstructured":"Goldstein BH, Birk CL et al (2009) Ovarian cancer and late onset paraneoplastic cerebellar degeneration. Arch Gynecol Obstet 280(1):99\u2013101","journal-title":"Arch Gynecol Obstet"},{"key":"22_CR9","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1046\/j.1460-9568.1999.00864.x","volume":"11","author":"J Honorat","year":"1999","unstructured":"Honorat J, Byk T, Kusters I et al (1999) Ulip\/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes. Eur J Neurosci 11:4226\u20134232","journal-title":"Eur J Neurosci"},{"issue":"4","key":"22_CR10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/jnnp.2007.138016","volume":"80","author":"J Honnorat","year":"2009","unstructured":"Honnorat J, Cartalat-Carel S, Ricard D, Camdessanche JP, Carpentier AF, Rogemond V, Chapuis F, Aguera M, Decullier E, Duchemin AM, Graus F, Antoine JC (2009) Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2\/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 80(4):412\u2013416","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"22_CR11","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00415-006-0471-x","volume":"254","author":"A Ar\u00e9s-Luque","year":"2007","unstructured":"Ar\u00e9s-Luque A, Garc\u00eda-Tu\u00f1\u00f3n LA, Saiz A et al (2007) Isolated paraneoplastic optic neuropathy associated with small-cell lung cancer and anti-CV2 antibodies. J Neurol 254(8):1131\u20131132","journal-title":"J Neurol"},{"issue":"2","key":"22_CR12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","volume":"49","author":"Z Yu","year":"2001","unstructured":"Yu Z, Kryzer TJ, Griesmann GE et al (2001) CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49(2):146\u2013154","journal-title":"Ann Neurol"},{"key":"22_CR13","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135\u20131140","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"22_CR14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1468-1331.2007.01802.x","volume":"14","author":"O Stich","year":"2007","unstructured":"Stich O, Rauer S (2007) Antigen-specific oligoclonal bands in cerebrospinal fluid and serum from patients with anti-amphiphysin- and anti-CV2\/CRMP5 associated paraneoplastic neurological syndromes. Eur J Neurol 14:650\u2013653","journal-title":"Eur J Neurol"},{"key":"22_CR15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000051680","volume":"202","author":"E Buxtorf H\u00fcbscher","year":"2001","unstructured":"Buxtorf H\u00fcbscher E, Panizzon R (2001) Bazex syndrome. Dermatology 202:350\u2013352","journal-title":"Dermatology"},{"key":"22_CR16","first-page":"516","volume":"22(Suppl 3)","author":"PK Pillay","year":"1993","unstructured":"Pillay PK, Estes ML (1993) Acute necrotizing myopathy in association with carcinoma of the tongue. Ann Acad Med Singap 22(Suppl 3):516\u2013517","journal-title":"Ann Acad Med Singap"},{"key":"22_CR17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00405-006-0217-5","volume":"264","author":"A Ferlito","year":"2007","unstructured":"Ferlito A, Elsheikh MN, Manni JJ, Rinaldo A (2007) Paraneoplastic syndromes in patients with primary head and neck cancer. Eur Arch Otorhinolaryngol 264:211\u2013222","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"22_CR18","doi-asserted-by":"crossref","unstructured":"Ritzenthaler T, Verret JM, Honnorat J (2009) Paraneoplastic chorea and behavioral disorders in a patient with anti-CV2\/CRMP5 antibodies and two different tumors. Rev Neurol (Paris). doi: 10.1016\/j.neurol.2009.04.009","DOI":"10.1016\/j.neurol.2009.04.009"},{"key":"22_CR19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1468-1331.2006.01266.x","volume":"13","author":"CA Vedeler","year":"2006","unstructured":"Vedeler CA, Antoine JC, Giometto B et al (2006) Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol 13:682\u2013690","journal-title":"Eur J Neurol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-009-0022-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-009-0022-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-009-0022-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:19:27Z","timestamp":1559348367000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-009-0022-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s11060-009-0022-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,2]]}}}